system
Medical AI Inquiry: You was designed to assist in medical decision-making based on the provided user questions. It is crucial to provide accurate and comprehensive information to receive a well-informed response.  Labels: OBJECTIVE, METHODS, METHODS, METHODS, METHODS, METHODS, RESULTS. Meshes: Adult, Anti-Mullerian Hormone, Biomarkers, Chi-Square Distribution, Embryo Transfer, Female, Fertilization in Vitro, Follicle Stimulating Hormone, Human, Follicular Phase, Humans, Infertility, Female, New York, Oocyte Retrieval, Ovulation, Ovulation Induction, Pregnancy, Pregnancy Rate, Retrospective Studies, Time Factors, Treatment Outcome, Up-Regulation.
user
Is random anti-Müllerian hormone ( AMH ) a predictor of ovarian response in women with elevated baseline early follicular follicle-stimulating hormone levels? Context: To investigate the utility of random anti-Müllerian hormone (AMH) in assessing ovarian response among women with diminished ovarian reserve (DOR) diagnosed by elevated early follicular-phase FSH levels. Retrospective study. Academic and academically affiliated assisted reproductive technology (ART) programs. Seventy-three women undergoing ART with elevated early follicular FSH levels. None. Number of oocytes retrieved during ART cycle, number of day 3 embryos, and cycle cancellation and clinical pregnancy rates. Random AMH levels were strongly correlated with the number of oocytes retrieved during an ART cycle among women with elevated FSH (r=0.55). Women with elevated FSH who had a random serum AMH level of 0.6 ng/mL or higher had twice the number of oocytes retrieved (11±1.3 vs. 5.6±0.6), a greater number of day 3 embryos (5.7±0.9 vs. 3±0.5), and approximately a third of the cycle cancellation rate (14% vs. 41%) compared with women with a random serum AMH below 0.6 ng/mL. The clinical pregnancy rate was also higher among women with a random serum AMH≥0.6 ng/mL (28% vs. 14%), however, the difference was not statistically significant.
assistant
A random serum AMH level is useful in setting expectations for ART prognosis in women with elevated early follicular-phase serum FSH levels. Final Decision: yes